D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 108 Citations 56,082 370 World Ranking 2673 National Ranking 1550

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Disease

Mark J. Sarnak mostly deals with Internal medicine, Kidney disease, Renal function, Risk factor and Endocrinology. His Internal medicine study incorporates themes from Surgery and Cardiology. His Kidney disease research incorporates themes from Nephropathy, Cause of death, Blood pressure, Intensive care medicine and Kidney.

Mark J. Sarnak works mostly in the field of Renal function, limiting it down to topics relating to Cholesterol and, in certain cases, Urine. His study in Risk factor is interdisciplinary in nature, drawing from both Cohort study, Anemia, Disease, Vascular disease and Heart disease. His work deals with themes such as Gastroenterology and Confidence interval, which intersect with Endocrinology.

His most cited work include:

  • Clinical epidemiology of cardiovascular disease in chronic renal disease. (3311 citations)
  • Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. (3113 citations)
  • Cystatin C and the risk of death and cardiovascular events among elderly persons. (1033 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Internal medicine, Kidney disease, Renal function, Endocrinology and Cardiology. Internal medicine is closely attributed to Gastroenterology in his work. His Kidney disease research is multidisciplinary, incorporating perspectives in Nephrology, Surgery, Intensive care medicine, Disease and Kidney.

The various areas that Mark J. Sarnak examines in his Renal function study include Creatinine, Heart failure and Diabetes mellitus. His research in Endocrinology tackles topics such as Cohort study which are related to areas like Cohort. The study incorporates disciplines such as Anemia and Epidemiology in addition to Risk factor.

He most often published in these fields:

  • Internal medicine (79.81%)
  • Kidney disease (60.10%)
  • Renal function (51.54%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (79.81%)
  • Kidney disease (60.10%)
  • Renal function (51.54%)

In recent papers he was focusing on the following fields of study:

Mark J. Sarnak mainly investigates Internal medicine, Kidney disease, Renal function, Cardiology and Hazard ratio. His Internal medicine study frequently draws connections between adjacent fields such as Endocrinology. His Kidney disease study integrates concerns from other disciplines, such as Blood pressure, Intensive care medicine, Disease, Kidney and Risk factor.

His Renal function study combines topics from a wide range of disciplines, such as Creatinine, Urine, Diabetes mellitus and Urology. Mark J. Sarnak interconnects Stroke, White matter and Kidney transplantation in the investigation of issues within Cardiology. His studies deal with areas such as Oncology and End stage renal disease as well as Hazard ratio.

Between 2016 and 2021, his most popular works were:

  • Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference (190 citations)
  • Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review. (88 citations)
  • Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies (78 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Surgery

His primary areas of investigation include Kidney disease, Internal medicine, Renal function, Risk factor and Diabetes mellitus. His studies in Kidney disease integrate themes in fields like Dialysis, Intensive care medicine, Blood pressure and Cardiology. His study ties his expertise on Endocrinology together with the subject of Internal medicine.

His Renal function research includes themes of Hazard ratio, Confidence interval, Disease, Creatinine and Cohort. His work carried out in the field of Risk factor brings together such families of science as Epidemiology, Cognitive test, Neurocognitive, Physical therapy and Pediatrics. His research investigates the connection between Diabetes mellitus and topics such as Nephrology that intersect with problems in Montreal Cognitive Assessment, Logistic regression, Decreased glomerular filtration rate and Tubulointerstitial fibrosis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Clinical epidemiology of cardiovascular disease in chronic renal disease.

Robert N. Foley;Patrick S. Parfrey;Mark J. Sarnak.
American Journal of Kidney Diseases (1998)

5993 Citations

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Mark J. Sarnak;Andrew S. Levey;Anton C. Schoolwerth;Josef Coresh.
Circulation (2003)

5472 Citations

Cystatin C and the risk of death and cardiovascular events among elderly persons.

Michael G. Shlipak;Mark J. Sarnak;Ronit Katz;Linda F. Fried.
The New England Journal of Medicine (2005)

1419 Citations

Epidemiology of cardiovascular disease in chronic renal disease.

R N Foley;P S Parfrey;M J Sarnak.
Journal of The American Society of Nephrology (1998)

1379 Citations

CHRONIC KIDNEY DISEASE AS A RISK FACTOR FOR CARDIOVASCULAR DISEASE AND ALL-CAUSE MORTALITY: A POOLED ANALYSIS OF COMMUNITY-BASED STUDIES

Daniel E. Weiner;Hocine Tighiouart;Manish G. Amin;Paul C. Stark.
Journal of The American Society of Nephrology (2004)

1308 Citations

Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients

Alfred K. Cheung;Mark J. Sarnak;Guofen Yan;Johanna T. Dwyer.
Kidney International (2000)

1027 Citations

K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease

Andrew S. Levey;Michael V. Rocco;Sharon Anderson;Sharon P. Andreoli.
American Journal of Kidney Diseases (2004)

1017 Citations

Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction.

Amin Al-Ahmad;William M Rand;Guruprasad Manjunath;Marvin A Konstam.
Journal of the American College of Cardiology (2001)

986 Citations

Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community.

Guruprasad Manjunath;Hocine Tighiouart;Hassan N. Ibrahim;Bonnie MacLeod.
Journal of the American College of Cardiology (2003)

949 Citations

Cardiovascular disease and chronic renal disease: a new paradigm.

Mark J. Sarnak;Andrew S. Levey.
American Journal of Kidney Diseases (2000)

747 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Mark J. Sarnak

Josef Coresh

Josef Coresh

Johns Hopkins University

Publications: 277

Michael G. Shlipak

Michael G. Shlipak

University of California, San Francisco

Publications: 273

Csaba P. Kovesdy

Csaba P. Kovesdy

University of Tennessee Health Science Center

Publications: 209

Kamyar Kalantar-Zadeh

Kamyar Kalantar-Zadeh

University of California, Irvine

Publications: 188

Andrew S. Levey

Andrew S. Levey

Tufts Medical Center

Publications: 169

Joachim H. Ix

Joachim H. Ix

University of California, San Diego

Publications: 162

Peter Stenvinkel

Peter Stenvinkel

Karolinska Institute

Publications: 144

Caroline S. Fox

Caroline S. Fox

National Institutes of Health

Publications: 133

Bengt Lindholm

Bengt Lindholm

Karolinska Institute

Publications: 121

Marcello Tonelli

Marcello Tonelli

University of Calgary

Publications: 119

Michel Chonchol

Michel Chonchol

University of Colorado Anschutz Medical Campus

Publications: 115

Juan Jesus Carrero

Juan Jesus Carrero

Karolinska Institute

Publications: 112

Carmine Zoccali

Carmine Zoccali

National Academies of Sciences, Engineering, and Medicine

Publications: 112

Adeera Levin

Adeera Levin

University of British Columbia

Publications: 112

George L. Bakris

George L. Bakris

University of Chicago

Publications: 111

Anna Köttgen

Anna Köttgen

University of Freiburg

Publications: 106

Trending Scientists

Michael Witbrock

Michael Witbrock

University of Auckland

John Krogstie

John Krogstie

Norwegian University of Science and Technology

Flemming Nielson

Flemming Nielson

Technical University of Denmark

Linda Argote

Linda Argote

Carnegie Mellon University

Yu.A. Ovchinnikov

Yu.A. Ovchinnikov

Russian Academy of Sciences

Pedro Amorós

Pedro Amorós

University of Valencia

Andrew J. Griffith

Andrew J. Griffith

National Institutes of Health

Yanhui Hu

Yanhui Hu

Harvard University

Jane A. Langdale

Jane A. Langdale

University of Oxford

Zhongtang Yu

Zhongtang Yu

The Ohio State University

Andreas S. Reichert

Andreas S. Reichert

Heinrich Heine University Düsseldorf

Beverly E. Griffin

Beverly E. Griffin

Imperial College London

Werner Singer

Werner Singer

University of Rostock

Axel Schippers

Axel Schippers

Federal Institute for Geosciences and Natural Resources

Ignacio Torres-Aleman

Ignacio Torres-Aleman

Cajal Institute

P. Christopher Earley

P. Christopher Earley

London Business School

Something went wrong. Please try again later.